Continuous infusion of local anaesthetic in the control of pain following colorectal surgery
Mazda Foundation - Private Bag 40, Mount Waverley BC, Vic 3149
300 participants
Dec 6, 2004
Interventional
Conditions
Summary
To determine if there is a better and safer option for pain relief following laparotomies for colorectal surgery, by using a continuous infusion of local anaesthetic into the wound.
Eligibility
Inclusion Criteria1
- Undergoing open colorectal surgery (excluding abdomino-perineal resections) and that there is written informed consent.
Exclusion Criteria1
- Allergies to lignocaine or ropivacaine, true allergy to morphine, epidural or intrathecal infusions, emergency surgery, and if the patient is mentally or legally incapacitated or if the have a prior history of altered mental state.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
To determine whether continous local anaesthetic, ie. ropivacaine 1% (Naropin - produced by AstroZeneca) via a dual catheter PainBuster Soaker Pain Management System (produced by I-Flow) is a more effective form of post operative analgesia compared to traditional analgesias for midline incisions following major colorectal resections. The PainBuster Soaker System is tested in a randomised double blinded control study where participants either receive ropivacaine 1% or Saline in their PainBuster Device for the first three days. Both groups also receive a Morphine PCA, Tramadol, Ketorolac and Panadol.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000347662